title: In primary prevention, the ACC/AHA risk-based approach predicted ASCVD better than trial-based or hybrid approaches.
authors.forename: Michael
authors.initials: M
authors.lastname: Blaha
mesh_terms: D050197:Atherosclerosis / Q000517:prevention & control*; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D011322:Primary Prevention / Q000379:methods*; D018570:Risk Assessment / Q000379:methods*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors